45 results on '"Ding, Junli"'
Search Results
2. B7-H3 is associated with the armored-cold phenotype and predicts poor immune checkpoint blockade response in melanoma
3. STAT3/miR-130b-3p/MBNL1 feedback loop regulated by mTORC1 signaling promotes angiogenesis and tumor growth
4. Analysis of Spatiotemporal Changes, Influencing Factors, and Coupling Coordination Degree of Urban Human Settlements Efficiency: A Case Study of Megacities and Supercities in China
5. Prognostic nomogram in patients with gastrointestinal stromal tumors: a SEER-based study
6. Study on strategy of CT image sequence segmentation for liver and tumor based on U-Net and Bi-ConvLSTM
7. Research Progress of Immunoscore in Prediction of Tumor Prognosis and Efficacy to Treatment
8. Myosin light chain kinase inhibitor ML7 improves vascular endothelial dysfunction and permeability via the mitogen-activated protein kinase pathway in a rabbit model of atherosclerosis
9. PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer
10. The emerging roles of circular RNAs in ovarian cancer
11. Total T Cell Density and Expression of T Memory Stem Cell Markers are Associated with Better Prognosis in Colon Cancer
12. Systematic analysis of markers for T‐cell differentiation revealing CD95 as a novel biomarker for prognosis and immunotherapeutic efficacy in colon cancer.
13. Tislelizumab combined with anlotinib and chemotherapy (XELOX) in the treatment of advanced gastric carcinoma: Preliminary results of a single-arm, open-label phase I/IIa trial (TALENT study).
14. A Game Strategy Study on Innovation Efficiency of China’s Listed Charging Pile Companies: Based on Generalized Fuzzy DEA Method
15. Agricultural carbon emission efficiency evaluation and influencing factors in Zhejiang province, China
16. NEUROD1 predicts better prognosis in pancreatic cancer revealed by a TILs-based prognostic signature
17. Microfluidic devices: The application in TME modeling and the potential in immunotherapy optimization
18. Study on spatial-temporal characteristics and influencing factors of urban environmental resource efficiency in the Yangtze River Basin of China
19. The Clinical Significance of Deglycosylated PD-L1 Level Detection Using 28-8 Monoclonal Antibody in Lung Adenocarcinoma
20. Case Report: Successful Immunotherapy Improved the Prognosis of the Unfavorable Subset of Cancer of Unknown Primary
21. Additional file 1 of STAT3/miR-130b-3p/MBNL1 feedback loop regulated by mTORC1 signaling promotes angiogenesis and tumor growth
22. Additional file 2 of STAT3/miR-130b-3p/MBNL1 feedback loop regulated by mTORC1 signaling promotes angiogenesis and tumor growth
23. Supplemental Material, sj-docx-1-tct-10.1177_15330338211019442 - Removal of N-Linked Glycosylation Enhances PD-L1 Detection in Colon Cancer: Validation Research Based on Immunohistochemistry Analysis
24. Supplemental Material, sj-docx-3-tct-10.1177_15330338211019442 - Removal of N-Linked Glycosylation Enhances PD-L1 Detection in Colon Cancer: Validation Research Based on Immunohistochemistry Analysis
25. Supplemental Material, sj-docx-5-tct-10.1177_15330338211019442 - Removal of N-Linked Glycosylation Enhances PD-L1 Detection in Colon Cancer: Validation Research Based on Immunohistochemistry Analysis
26. Supplemental Material, sj-docx-4-tct-10.1177_15330338211019442 - Removal of N-Linked Glycosylation Enhances PD-L1 Detection in Colon Cancer: Validation Research Based on Immunohistochemistry Analysis
27. Supplemental Material, sj-docx-2-tct-10.1177_15330338211019442 - Removal of N-Linked Glycosylation Enhances PD-L1 Detection in Colon Cancer: Validation Research Based on Immunohistochemistry Analysis
28. Removal of N-Linked Glycosylation Enhances PD-L1 Detection in Colon Cancer: Validation Research Based on Immunohistochemistry Analysis
29. The Correlation between Deglycosylation of PD-L1 and Gene Mutations and Their Effects on the Prognosis of Patients with Lung Adenocarcinoma
30. RNA-Seq Profiling of Circular RNAs and the Oncogenic Role of circPVT1 in Cutaneous Squamous Cell Carcinoma
31. MicroRNA‑23b‑3p promotes pancreatic cancer cell tumorigenesis and metastasis via the JAK/PI3K and Akt/NF‑κB signaling pathways
32. PSMC2 is Up-regulated in Pancreatic Cancer and Promotes Cancer Cell Proliferation and Inhibits Apoptosis
33. All‑trans retinoic acid reduces endothelin‑1 expression and increases endothelial nitric oxide synthase phosphorylation in rabbits with atherosclerosis
34. Upregulated exosomic miR-23b-3p plays regulatory roles in the progression of pancreatic cancer
35. Effects and Mechanism of Action of Inducible Nitric Oxide Synthase on Apoptosis in a Rat Model of Cerebral Ischemia‐Reperfusion Injury
36. All-trans retinoic acid reduces endothelin-1 expression and increases endothelial nitric oxide synthase phosphorylation in rabbits with atherosclerosis.
37. HEPACAM inhibited the growth and migration of cancer cells in the progression of non-small cell lung cancer
38. Effects and Mechanism of Action of Inducible Nitric Oxide Synthase on Apoptosis in a Rat Model of Cerebral Ischemia-Reperfusion Injury.
39. HEPACAM inhibited the growth and migration of cancer cells in the progression of non-small cell lung cancer.
40. Down-Regulation of Tumor Necrosis Factor-Associated Factor 6 Is Associated with Progression of Acute Pancreatitis Complicating Lung Injury in Mice
41. Angiotensin receptor blocker attacks armored and cold tumors and boosts immune checkpoint blockade.
42. miR-224 Regulates the Aggressiveness of Hepatoma Cells Through the IL-6/STAT3/SMAD4 Pathway.
43. MicroRNA-23b-3p promotes pancreatic cancer cell tumorigenesis and metastasis via the JAK/PI3K and Akt/NF-κB signaling pathways.
44. Effects and Mechanism of Action of Inducible Nitric Oxide Synthase on Apoptosis in a Rat Model of Cerebral Ischemia-Reperfusion Injury.
45. HEPACAM inhibited the growth and migration of cancer cells in the progression of non-small cell lung cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.